+

Visit Booth #1232

TCT 2025: Beyond the Beat: Navitor™ in Motion

An immersive extended reality experience showcasing the precision and innovation of the Navitor™ TAVI system.

Save your Spot

October 26 – 28, 2025 | 8:00 AM – 6:00 PM    Abbott Booth #1232

Innovation in Transcatheter Aortic Valve Implantation

Experience the future of transcatheter valve therapy at TCT 2025. Step into a clinically driven journey where innovation meets precision through an extended reality look at the Navitor TAVI system. Space is limited. Register now to secure your spot.

Please select your preferred time below and provide your information so we can confirm your spot. If your preferred time is not available, please email us and we will contact you if space becomes available.

Abbott TAVI at TCT 2025

SCIENTIFIC SYMPOSIUM

Monday, October 27, 2025
12:15 – 1:30 PM

Contemporary TAVI: The VISION for Optimizing Procedural Outcomes

Explore strategies to enhance procedural efficiency and outcomes in transcatheter aortic valve implantation. This symposium brings together leading voices in the field to share the latest insights shaping contemporary TAVI practice.

Presentation Theater 1, Hall D, Exhibition Level, Moscone South

Add to calendar

Featured experts:

Dr. Santiago Garcia
Co-moderator

Dr. Ibrahim Sultan
Co-moderator

Dr. Stephanie Sellers

Dr. Michael Reardon

Dr. Deepak Talreja

Dr. Dustin Kliner

Dr. Michael Ragosta

Dr. John Saxon

PODIUM PRESENTATIONS

Saturday, October 25, 2025
11:00 AM

Thirty-Day and One-Year Outcomes of the Navitor TAVR System in Patients with Low or Intermediate Risk

Presenter: Dr. Stephen Worthley

Presentation Theater 4, Hall E, Exhibition Level, Moscone North

Add to calendar

Monday, October 27, 2025
2:13 PM

A Novel Balloon-Expandable TAVR System: Initial Insights from the Early Feasibility Study

Presenter: Dr. Azeem Latib

Innovation Theater, Hall E, Exhibition Level, Moscone North

Add to calendar

Tuesday, October 28, 2025
12:30 PM

Four-Year Clinical Outcomes with an Intra-Annular Self-Expanding Transcatheter Aortic Valve

Presenter: Dr. Ganesh Manoharan

Station 1, Hall D, Exhibition Level, Moscone South

Add to calendar

VALVE COORDINATOR DINNER

Saturday, October 25, 2025
5:30 – 8:30 PM

Managing the Expanding Structural Heart Priorities for Valve Coordinators

Join us for an evening of collaborative discussion around the growing priorities and how to prepare for the evolving structural heart program needs. Dive into next-generation technologies for improving quality outcomes and planning for lifetime management.

Morton's The Steakhouse, San Francisco

Register

Explore Abbott’s Structural Heart Portfolio

NAVITOR

Navitor is a next-generation transcatheter aortic valve implantation (TAVI) system built for stable delivery, excellent hemodynamics, and long-term value. Its Vision-Valves accommodate a wide range of anatomies, while the FlexNav delivery system enhances precision and access—even in challenging vessels.

Learn more about Navitor

MAT-2511694 v2.0 | Item approved for U.S. use only.

Important Safety Information
  • Navitor

  • Rx Only

    NAVITOR™ TRANSCATHETER AORTIC VALVE IMPLANTATION SYSTEM

    INDICATIONS

    The Navitor™ Transcatheter Aortic Valve Implantation System is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical comorbidities unmeasured by the STS risk calculator).

    CONTRAINDICATIONS  

    The valve is contraindicated for patients with inability to tolerate antiplatelet/anticoagulant therapy or nitinol alloy (nickel and titanium), or who have active infections, including endocarditis.

    POTENTIAL ADVERSE EVENTS  

    Adverse events potentially associated with the use of transcatheter bioprosthetic heart valves include but are not limited to: access site complications (e.g., pain, bleeding, infection, hematoma, pseudoaneurysm, etc.); acute coronary obstruction; acute myocardial infarction; allergic reaction to antiplatelet agents, contrast medium, or valve components; aortic rupture; ascending aorta trauma; atrio-ventricular node block; cardiac arrhythmias; conduction system injury; conversion to open surgical procedure; death; dissection; embolism; emergent balloon valvuloplasty; emergent percutaneous coronary intervention (PCI); emergent surgery (i.e., coronary artery bypass, heart valve replacement); endocarditis; explantation; heart failure; hemodynamic compromise; hemolysis; hemolytic anemia; hemorrhage; hypotension or hypertension; infection; myocardial ischemia; mitral valve insufficiency; multi-organ failure; non-structural dysfunction (i.e., entrapment by pannus, paravalvular leak, inappropriate sizing or positioning); pannus; pericardial effusion; perforation of the myocardium, ventricle, or a blood vessel; permanent disability; permanent pacemaker; regurgitation; renal insufficiency or renal failure; reoperation; respiratory failure; sepsis; stroke; structural deterioration (i.e., calcification, leaflet tear); thrombosis; tamponade; transfusion; valve embolization or migration; vessel dissection or spasm.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. VISITOR INTERNATIONAL VISITOR

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel
+